Therapeutic Approaches for Inhibition of Protein Aggregation in Huntington's Disease - Wikidata - wikimedia - TriplyDB

Therapeutic Approaches for Inhibition of Protein Aggregation in Huntington's Disease

Therapeutic Approaches for Inhibition of Protein Aggregation in Huntington's Disease

http://www.wikidata.org/entity/Q27022757

about

Alternative mitochondrial electron transfer for the treatment of neurodegenerative diseases and cancers: Methylene blue connects the dots.Car drivers with dementia: Different complications due to different etiologies?Hope for Huntington's disease? A novel approach for disease modification.Mammalian display screening of diverse cystine-dense peptides for difficult to drug targets.Fractionation for Resolution of Soluble and Insoluble Huntingtin Species.The role of Twist1 in mutant huntingtin-induced transcriptional alterations and neurotoxicity Aggregated SOD1 causes selective death of cultured human motor neurons

P2860

Q36913723-67498BF3-B13F-4A55-86E4-704696D2121E Q38421354-3FD61A0C-6D10-44ED-8702-F2457CE77DFA Q45299657-921ACA6F-AF62-44D2-8F70-D19A22548FED Q47133162-A664F1B0-D12D-4969-8848-A2C06A335769 Q52350721-411B3612-91DE-4BDE-9E68-10652942D0C0 Q56770267-6A78E81F-9D02-436A-BE77-37742DC7DE93 Q58608836-094E150A-9887-464D-9B62-02E8B1FDAA4B

P2860

Therapeutic Approaches for Inhibition of Protein Aggregation in Huntington's Disease

http://www.wikidata.org/entity/Q27022757

description

2014 nî lūn-bûn

@nan

2014 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մարտին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Therapeutic Approaches for Inhibition of Protein Aggregation in Huntington's Disease

@ast

Therapeutic Approaches for Inhibition of Protein Aggregation in Huntington's Disease

@en

Therapeutic Approaches for Inhibition of Protein Aggregation in Huntington's Disease

@nl

type

label

Therapeutic Approaches for Inhibition of Protein Aggregation in Huntington's Disease

@ast

Therapeutic Approaches for Inhibition of Protein Aggregation in Huntington's Disease

@en

Therapeutic Approaches for Inhibition of Protein Aggregation in Huntington's Disease

@nl

prefLabel

Therapeutic Approaches for Inhibition of Protein Aggregation in Huntington's Disease

@ast

Therapeutic Approaches for Inhibition of Protein Aggregation in Huntington's Disease

@en

Therapeutic Approaches for Inhibition of Protein Aggregation in Huntington's Disease

@nl

P1433

Q27022757-BE9CBC49-3716-4D66-BFC9-F305B4F4B498

P1476

Q27022757-2F9CF260-E37D-4D21-8F00-5AA5A051A5A2

P2093

Q27022757-154438A7-FBE0-4AD4-A9C2-A939BE8E4662

Q27022757-C9BE99C0-98DF-4C9A-9200-2795EB9D3EB8

P2860

Q27022757-048A67AC-89D4-4A63-923E-CC01B5DD79D3

Q27022757-08FECBCD-0430-4449-A052-CA60921262A7

Q27022757-097E1780-EEF5-4931-832A-ABF510F27E2C

Q27022757-0CD1B038-7196-4A84-A623-127AEACF9BA0

Q27022757-1140F9D0-2172-46A5-B106-7851CF7FEE90

Q27022757-11F52F2F-D1EE-40D4-B1E0-BA1C5E22823B

Q27022757-1496B479-63A9-4E4C-B158-327406E9F78A

Q27022757-1C207634-01FA-49D5-8718-966A47FF3EB1

Q27022757-1FE0C7A2-D6BC-4E51-A688-3489FEE4AD52

Q27022757-242BD0D4-C64E-4D23-A5F2-018124A9C346

P304

Q27022757-6D0E0ADB-5F31-40BA-BABE-27CE11E37A77

P31

Q27022757-E2ADEDBF-BAD6-4789-9E11-3D558E58BEDB

P356

Q27022757-2FA94A8A-8408-4A52-B72F-584B2767F29B

P407

Q27022757-113CEF00-5F1E-41AC-AC21-0A8DBC9DB9B3

P433

Q27022757-0D278ECC-AD76-42EB-890A-C8AAAC410E66

P478

Q27022757-CEAD5E2F-C8AB-4BB6-B7EC-77A266B47B12

P577

Q27022757-217AD8F7-5500-46D6-A46E-43BE1BE331EB

P5875

Q27022757-6C767A8B-15C5-4413-BE9F-8E9321F90A17

P698

Q27022757-13CBDD8E-12BF-4A2C-969A-CE01E4C74B83

P921

Q27022757-97D7E5A0-55F2-488C-8DE1-44767D4D3662

P932

Q27022757-17F4D668-1A69-4B29-BE5C-F386685831C7

P356

EN.2014.23.1.36

P1433

Experimental neurobiology

P1476

Therapeutic Approaches for Inhibition of Protein Aggregation in Huntington's Disease

@en

P2093

Kyong-Tai Kim

http://www.w3.org/2001/XMLSchema#string

Sangjune Kim

http://www.w3.org/2001/XMLSchema#string

P2860

The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription

A huntingtin-associated protein enriched in brain with implications for pathology

The selective macroautophagic degradation of aggregated proteins requires the PI3P-binding protein Alfy

Rhes, a striatal specific protein, mediates mutant-huntingtin cytotoxicity

Huntingtin and the molecular pathogenesis of Huntington's disease. Fourth in molecular medicine review series

Misfolded proteins partition between two distinct quality control compartments

Dual Action of ATP Hydrolysis Couples Lid Closure to Substrate Release into the Group II Chaperonin Chamber

Structural basis for inhibition of the Hsp90 molecular chaperone by the antitumor antibiotics radicicol and geldanamycin

Microtubule acetylation promotes kinesin-1 binding and transport.

Repression of heat shock transcription factor HSF1 activation by HSP90 (HSP90 complex) that forms a stress-sensitive complex with HSF1

P304

36-44

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5607/EN.2014.23.1.36

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P577

2014-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261745661

http://www.w3.org/2001/XMLSchema#string

P698

24737938

http://www.w3.org/2001/XMLSchema#string

P921

Huntington disease

P932

3984955

http://www.w3.org/2001/XMLSchema#string